Literature DB >> 25665531

Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.

Feng-Tao Liu1, Yan Chen2, Yu-Jie Yang3, Ling Yang4, Mei Yu5, Jian Zhao6, Jian-Jun Wu7, Fang Huang8, Wen Liu9, Zheng-Tong Ding10, Jian Wang11.   

Abstract

Mutations and excessive accumulation of α-synuclein (α-syn) can lead to the degeneration of dopaminergic neurons, indicating a pivotal role of α-syn in the pathogenesis of Parkinson's disease (PD). Although how α-syn contributes to PD is still elusive, mitochondrial impairments have been reported to be implicated in. Mortalin, a molecular chaperone mainly located in mitochondria, has been linked to the pathogenesis of PD in recent studies. Moreover, some proteomics studies indicate that mortalin is associated with PD-related proteins, including α-syn. Therefore it is of interest to understand the function of mortalin in the mitochondrial disruption induced by A53T α-syn overexpression. The present study modulated the expression of mortalin and detected the effect of mortalin on the mitochondrial impairments induced by A53T α-syn in SH-SY5Y cells. Our data revealed that A53T α-syn could disrupt mitochondrial dynamics and increase the neuronal susceptibility to neurotoxin rotenone. The expression of mortalin decreased significantly in dopaminergic cells overexpressing A53T α-syn; furthermore, the down-regulation of mortalin could attenuate the disrupted mitochondrial dynamics by reducing α-syn translocation to mitochondria, suggesting that a compensatory mechanism of mortalin might be implicated in the pathogenesis of PD.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  A53T mutant α-synuclein; Mitochondrial dynamics; Mitochondrial translocation of α-synuclein; Mortalin; Parkinson׳s disease

Mesh:

Substances:

Year:  2015        PMID: 25665531     DOI: 10.1016/j.brainres.2015.01.050

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Ischemic postconditioning influences electron transport chain protein turnover in Langendorff-perfused rat hearts.

Authors:  Song Cao; Yun Liu; Haiying Wang; Xiaowen Mao; Jincong Chen; Jiming Liu; Zhengyuan Xia; Lin Zhang; Xingkui Liu; Tian Yu
Journal:  PeerJ       Date:  2016-02-16       Impact factor: 2.984

2.  Glucose-regulated protein 75 determines ER-mitochondrial coupling and sensitivity to oxidative stress in neuronal cells.

Authors:  Birgit Honrath; Isabell Metz; Nadia Bendridi; Jennifer Rieusset; Carsten Culmsee; Amalia M Dolga
Journal:  Cell Death Discov       Date:  2017-11-06

Review 3.  Chaperone-Based Therapies for Disease Modification in Parkinson's Disease.

Authors:  Erik L Friesen; Mitch L De Snoo; Luckshi Rajendran; Lorraine V Kalia; Suneil K Kalia
Journal:  Parkinsons Dis       Date:  2017-08-21

4.  Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20.

Authors:  Briana R De Miranda; Emily M Rocha; Sandra L Castro; J Timothy Greenamyre
Journal:  NPJ Parkinsons Dis       Date:  2020-12-08

5.  Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson's Disease Pathology.

Authors:  Anna Wilkaniec; Anna M Lenkiewicz; Lidia Babiec; Emilia Murawska; Henryk M Jęśko; Magdalena Cieślik; Carsten Culmsee; Agata Adamczyk
Journal:  Front Aging Neurosci       Date:  2021-02-24       Impact factor: 5.750

6.  TonEBP modulates the protective effect of taurine in ischemia-induced cytotoxicity in cardiomyocytes.

Authors:  Y J Yang; Y Y Han; K Chen; Y Zhang; X Liu; S Li; K Q Wang; J B Ge; W Liu; J Zuo
Journal:  Cell Death Dis       Date:  2015-12-17       Impact factor: 8.469

Review 7.  Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?

Authors:  Victorio M Pozo Devoto; Tomas L Falzone
Journal:  Dis Model Mech       Date:  2017-09-01       Impact factor: 5.758

8.  Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein.

Authors:  Huan-Cheng Wu; Qun-Liang Hu; Shi-Jun Zhang; Yan-Min Wang; Zhan-Kui Jin; Ling-Fu Lv; Sai Zhang; Zhen-Lin Liu; Hong-Lian Wu; Ou-Mei Cheng
Journal:  Neural Regen Res       Date:  2018-08       Impact factor: 5.135

Review 9.  Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.

Authors:  Sandro Percário; Aline da Silva Barbosa; Everton Luiz Pompeu Varela; Antônio Rafael Quadros Gomes; Michelli Erica Souza Ferreira; Thayana de Nazaré Araújo Moreira; Maria Fani Dolabela
Journal:  Oxid Med Cell Longev       Date:  2020-10-12       Impact factor: 6.543

10.  Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.

Authors:  Safiah Ibrahim Althurwi; Jun Q Yu; Philip Beale; Fazlul Huq
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.